SNYNF — Sanofi
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1121404 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
2026-10-30
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 12,300,000,000 | 9,283,000,000 | 2,384,000,000 | 343,000,000 | 129,060,000,000 | 6,350,000,000 | 59,493,000,000 |
| Mar 2026 | 11,244,000,000 | 8,106,000,000 | 2,269,000,000 | 1,614,000,000 | 128,024,000,000 | 5,544,000,000 | 54,881,000,000 |
| Dec 2025 | 12,205,000,000 | 8,449,000,000 | 1,630,000,000 | -801,000,000 | 126,805,000,000 | 7,657,000,000 | 55,095,000,000 |
| Sep 2025 | 13,170,000,000 | 9,758,000,000 | 3,785,000,000 | 2,802,000,000 | 129,794,000,000 | 8,906,000,000 | 56,261,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$11,837,000,000
Investing CF
$-13,293,000,000
Financing CF
$-7,050,000,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$4.21
As of
2026-08-09
Yahoo Snapshot (yfinance, live)
Total Revenue
$48,918,999,040
EBITDA
$13,543,000,064
Free Cash Flow
$6,298,999,808
Enterprise Value
$118,247,759,872
Total Cash
$6,350,000,128
Total Debt
$23,576,000,512
Shares Out
1,198,068,685
Trailing EPS
$3.77
Book Value
$67.20
ROE
5.7%
ROA
5.1%
Div Yield
5.76%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 46,716,000,000 | 9,597,000,000 | 7,813,000,000 | 126,805,000,000 | 55,095,000,000 | 71,376,000,000 | 10,750,000,000 |
| Dec 2024 | 44,286,000,000 | 8,923,000,000 | 5,560,000,000 | 132,798,000,000 | 54,941,000,000 | 77,507,000,000 | 9,081,000,000 |
| Dec 2023 | 41,618,000,000 | 8,691,000,000 | 5,400,000,000 | 126,464,000,000 | 52,111,000,000 | 74,040,000,000 | 10,258,000,000 |
| Dec 2022 | 40,561,000,000 | 10,926,000,000 | 8,371,000,000 | 126,722,000,000 | 51,570,000,000 | 74,784,000,000 | 10,526,000,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$9.25
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.04T | $1169.60 | — |
| JNJ | JOHNSON & JOHNSON | $618.09B | $256.48 | — |
| ABBV | AbbVie Inc. | $481.40B | $272.42 | — |
| MRK | Merck & Co., Inc. | $351.28B | $142.38 | — |
| NVS | NOVARTIS AG | $272.01B | $143.11 | — |
News headlines (Yahoo Finance, 1h cache)
Vallourec (ENXTPA:VK) Names A New Digital Chief, Is It Still 32% Below Fair Value?
2026-10-08 22:17 · Yahoo
Pharma’s $500B patent problem will come in waves — not as a cliff
2026-10-08 13:00 · Yahoo
Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and Quality
2026-10-08 11:03 · Yahoo
European Equities Traded in US as ADRs Fall in Wednesday Trading
2026-10-07 15:09 · Yahoo
Plozasiran Sales Forecast and Market Size Analysis - 2034 Report Reveals How Quarterly Dosing and Up to 74% Triglyceride Reduction Position Arrowhead's siRNA Across the 7MM
2026-10-07 11:49 · Yahoo
Expanded Sanofi Alliance And New Pipeline Data Could Be A Game Changer For Regeneron (REGN)
2026-10-06 22:09 · Yahoo
Novavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?
2026-10-06 06:13 · Yahoo
Press Release : Availability of the aide-mémoire for Q3 2026 results
2026-10-06 05:30 · Yahoo
Housekeeping Starts with Branding: Vicapsys Life Sciences Adopts New Corporate Identity Developed by FutureBrand for Vicapsys and Its Stateline Subsidiary
2026-10-05 12:00 · Yahoo
Stocktwits Biotech Dealmaker — Novartis, Sanofi And Novo Sign Week’s Biggest Deals
2026-10-03 00:13 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.